Clinical Trials Directory

Trials / Completed

CompletedNCT00649246

Prospective Assessment in Newborns for Diabetes Autoimmunity

1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D

Status
Completed
Phase
Study type
Observational
Enrollment
25,055 (actual)
Sponsor
Augusta University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is an observational study designed to help researchers understand the genetics and pathogenesis of type 1 diabetes, and to identify biomarkers for disease and disease complication prediction.

Detailed description

This study is designed to identify people who are at risk for developing type 1 diabetes, based on their genetics, family history and autoimmunity status, and to understand the role genetics plays in the development of the complications associated with type 1 diabetes in patients already affected by type 1 diabetes.

Conditions

Timeline

Start date
1997-07-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2008-04-01
Last updated
2018-03-27

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00649246. Inclusion in this directory is not an endorsement.